4 results
Approved WMOCompleted
Primary Objective: The primary objective of this prospective clinical trial is to determine the pharmacokinetic variability of SXT (960 mg) in patients receiving TB treatment. With these pharmacokinetic parameters, a population model and limited…
Approved WMOCompleted
ACT reduces the incidence of PTS after DVT. In the Dutch CBO-guidelines current therapy is adviced for 2 years after diagnosis because most PTS develops within 2 years after DVT, with a peak incidence in the first year.Some clinicians claim that one…
Approved WMOCompleted
Evaluate the effect of tedalinab on ECG parameters, CNS Function and Pain Perception in Healthy Subjects.
Approved WMOCompleted
"the effects of elastic stockings after varicose vein surgery".